Recidiva de hipertiroidismo en una paciente con la enfermedad de Graves tiroidectomizada hace 15 años

Conejero, J.L. Vercher; Rivas-Sanchez, A.; Bello-Arqués, P.; Ruiz-Llorca, C.; Falgas-Lacueva, M.; Pelegrí-Martínez, L.

doi:10.1016/j.remn.2011.06.004

Cited by 2 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Este tejido ectópico suele pasar desapercibido, ya que no genera síntomas, sin embargo puede desarrollar las mismas patologías que el tejido tiroideo normal. Los casos de recurrencia de la enfermedad de Graves tras tiroidectomía se deben más frecuentemente a remanentes en el tracto piramidal o tireotímico [1][2][3][4] .…”

Section: Discusión Y Conclusionesunclassified

Enfermedad de Graves recurrente tras tiroidectomía

Castro-Dufourny

2018

reccmi

View full text Add to dashboard Cite

La enfermedad de Graves es una causa frecuente de hipertiroidismo en mujeres jóvenes. Su tratamiento inicial suele realizarse con fármacos antitiroideos orales mantenidos a lo largo de 12-24 meses. Si persiste el hipertiroidismo tras este periodo, o si vuelve a presentarse tras un periodo libre de enfermedad, el segundo escalón terapéutico puede ser la cirugía o el yodo radiactivo. Presentamos el caso de una paciente con enfermedad de Graves resistente al tratamiento con antitiroideos orales, con recidiva del hipertiroidismo tras tiroidectomía total por existencia de tejido tiroideo ectópico mediastínico. Recibió tratamiento con yodo radiactivo, controlándose el hipertiroidismo, con hipotiroidismo yatrogénico posterior.

show abstract

Section: Discusión Y Conclusionesunclassified

Enfermedad de Graves recurrente tras tiroidectomía

Castro-Dufourny

2018

reccmi

View full text Add to dashboard Cite

show abstract

A Case of Recurrent Thyrotoxicosis in a Thyroglossal Duct Cyst 18 Years Following Thyroid Surgery

Baghaffar,

Samargandy

2023

Cureus

View full text Add to dashboard Cite

Graves' disease (GD) is an immune-mediated condition related to high thyroid-stimulating immunoglobulin levels. Here, we present a rare case of recurrent thyrotoxicosis that developed in a thyroglossal duct cyst (TGDC) and the residual thyroid tissue in a 46-year-old female following subtotal thyroidectomy. In 2005, she was diagnosed with GD causing thyrotoxicosis and treated with subtotal thyroidectomy. In 2022, she was seen at our clinic with a neck swelling gradually growing in size over the last 10 years. On examination, the mass was found to be moving with tongue protrusion. She was on thyroxin 100 mcg daily, and the dose was reduced gradually until she was maintained on no therapy for hypothyroidism and was still thyrotoxic. The combined clinical, laboratory thyroid scintigraphy and ultrasonographic features favored early developing recurrent Graves' disease in the thyroid residual and TGDC. She was started on carbimazole and was referred for surgery. Our case represents a rare occurrence of recurrent GD in the thyroid residual and TGDC.

show abstract

Recidiva de hipertiroidismo en una paciente con la enfermedad de Graves tiroidectomizada hace 15 años

Cited by 2 publications

References 3 publications

Enfermedad de Graves recurrente tras tiroidectomía

Enfermedad de Graves recurrente tras tiroidectomía

A Case of Recurrent Thyrotoxicosis in a Thyroglossal Duct Cyst 18 Years Following Thyroid Surgery

Contact Info

Product

Resources

About